A new analysis of brain imaging data reveals that lysergic acid diethylamide, commonly known as LSD, reduces the ...

Recent scientific exploration into psychedelics provides evidence that these powerful substances can profoundly reshape human ...

MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

In 1943, biochemist Albert Hoffman accidentally ingested a chemical that he had synthesized from a fungus and discovered that it created hallucinations. The mind-bending chemical was lysergic acid ...

A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD. Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the ...

LSD was first synthesized by Swiss chemist Albert Hofmann in 1938. He discovered its powerful psychoactive effects in 1943 after accidentally ingesting a small amount and experiencing vivid ...

Many of us know only one side of the story of psychedelic therapy. In the 1950s and early 1960s, psychiatrists gave LSD and mescaline to patients struggling with depression, anxiety, and addiction.

With LSD finally gaining mainstream acceptance — just last month, the FDA granted breakthrough status to an LSD formula to treat anxiety — author Norman Ohler investigates how it took so long for the ...